French firm wins funds for work on HIV/AIDS, obesity

04/10/2013 | GenomeWeb Daily News (free registration)

Theradiag, an in vitro diagnostics and theranostics company based in France, will use $1.6 million from Oséo to design test kits as part of its collaborative effort with Splicos and the French National Center for Research and Science. The project, called CaReNA, is aimed at developing diagnostic tests and RNA-targeting therapeutics for obesity and HIV/AIDS.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC